2022前三季度仅Q1收入311万,后两季度均无收入,营业利润继续亏损。
目前没有投资价值。查看全文
Aptevo Therapeutics(APVO)03-21 04:25
$Aptevo Therapeutics(APVO)$ S-1 General form for registration of securities under the Securities Act of 1933 Accession Number: 0000950170-24-034178 Act: 33 Size: 2 MB 网页链接查看全文
Aptevo Therapeutics(APVO)03-07 22:05
$Aptevo Therapeutics(APVO)$ 8-K Current report, items 8.01 and 9.01 Accession Number: 0000950170-24-027613 Act: 34 Size: 204 KB 网页链接查看全文
Aptevo Therapeutics(APVO)03-06 05:15
$Aptevo Therapeutics(APVO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-025915 Size: 10 KB 网页链接查看全文
Aptevo Therapeutics(APVO)03-06 05:15
$Aptevo Therapeutics(APVO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-025881 Size: 10 KB 网页链接查看全文
Aptevo Therapeutics(APVO)03-06 06:15
$Aptevo Therapeutics(APVO)$ 8-K Current report, items 5.03 and 9.01 Accession Number: 0000950170-24-026223 Act: 34 Size: 186 KB 网页链接查看全文
Aptevo Therapeutics(APVO)03-05 21:25
$Aptevo Therapeutics(APVO)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0000950170-24-025427 Act: 34 Size: 340 KB 网页链接查看全文
不入流资讯2023-08-02 17:21
$Aptevo Therapeutics(APVO)$ Aptevo Therapeutics slumps 25% after pricing of $5M public offering of 8M common shares at $0.62
Aptevo Therapeutics因定价每股0.62美元的800万股普通股的500万美元公开发行后暴跌25%。来自ChatGPT翻译查看全文
美股滚雪球2023-03-31 10:05
$Aptevo Therapeutics(APVO)$ 已经筹集了960万美元的非稀释性资金,将其现金延长到12个月以上。
公司通过完成向$标记临床研究(XOMA)$ 出售所有未来IXINITY延期付款和部分IXINITY里程碑的交易来筹集这笔资金。
在2023年第二季度,从2023年1月1日到2035年第一季度,XOMA将开始收到所有IXINIT...查看全文
逍遥投资派2023-01-10 23:50
$Aptevo Therapeutics(APVO)$ 5年来营收从1466万增长到3242万后迅速下滑到431万,2021年反弹回1230万,营业利润则是连续亏损5年,亏损幅度有所缩小,净利润除2017年外连续亏损4年。
2022前三季度仅Q1收入311万,后两季度均无收入,营业利润继续亏损。
目前没有投资价值。查看全文
牛唐2022-03-25 11:35
医药板块速评(2022.03.24)
本期内容提示:
1、AACR大会召开在即,有哪些医药股值得配置?
2、BVF、Baker Bro等机构纷纷抄底医药股,哪些公司有跟仓机会?
3、$Aptevo Therapeutics(APVO)爆拉,医药烟蒂股炒作成风,哪些标的有暴涨机会?
$恒瑞医药(SH600276)$ $金斯瑞生物...查看全文
牛唐2021-11-26 12:37
医药板块速评(2021.11.23)
本期内容提示:
1、APVO、KTTA等医药小票暴涨,哪些标的还有暴涨潜力?
2、医药板块止跌,是反转还是反弹?
3、ASH大会召开在即,哪些标的值得关注?
$Aptevo Therapeutics(APVO)$ $金斯瑞生物科技(01548)$ $天境生物(IMAB)$查看全文
$Aptevo Therapeutics(APVO)$ 424B5 - Prospectus [Rule 424(b)(5)] Filed: 2019-02-13 AccNo: 0001193125-19-038218 Size: 131 KB 网页链接
$Aptevo Therapeutics(APVO)$ SC 13G - Statement of acquisition of beneficial ownership by individuals Filed: 2019-02-12 AccNo: 0001037389-19-000008 Size: 13 KB 网页链接
$Aptevo Therapeutics(APVO)$ SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals Filed: 2019-02-12 AccNo: 0001144204-19-006624 Size: 102 KB 网页链接
$Aptevo Therapeutics(APVO)$ SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals Filed: 2019-02-08 AccNo: 0001258897-19-001030 Size: 52 KB 网页链接
$Aptevo Therapeutics(APVO)$ 8-K - Current report Filed: 2019-01-09 AccNo: 0001564590-19-000415 Size: 10 MBItem 2.02: Results of Operations and Financial ConditionItem 7.01: Regulation FD DisclosureItem 9.01: Financial Statements and Exhibits 网页链接
$Aptevo Therapeutics(APVO)$ S-3 - Registration statement under Securities Act of 1933 Filed: 2019-01-02 AccNo: 0001193125-19-000762 Size: 202 KB 网页链接
$Aptevo Therapeutics(APVO)$ 8-K - Current report Filed: 2018-12-24 AccNo: 0001564590-18-031354 Size: 718 KBItem 1.01: Entry into a Material Definitive AgreementItem 3.02: Unregistered Sales of Equity SecuritiesItem 9.01: Financial Statements and Exhibits 网页链接
$Aptevo Therapeutics Inc.(APVO)$ 8-K - Current report Filed: 2018-11-14 AccNo: 0001564590-18-029568 Size: 432 KBItem 2.02: Results of Operations and Financial ConditionItem 9.01: Financial Statements and Exhibits 网页链接
$Aptevo Therapeutics Inc.(APVO)$ 10-Q - Quarterly report [Sections 13 or 15(d)] Filed: 2018-11-14 AccNo: 0001564590-18-029562 Size: 12 MB 网页链接
$Aptevo Therapeutics Inc.(APVO)$ CORRESP [Cover] - Correspondence Filed: 2018-07-27 AccNo: 0001564590-18-017760 Size: 17 KB 网页链接